arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Insight Molecular Diagnostics Inc.

IMDX

$2.45 ▼ -0.20 (-7.55%) at close

13 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

Insight Molecular Diagnostics Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $74.7M

Dividend Yield —

Revenue Growth 115.6% ↗

Op. Margin —

ROIC 128.4% ↘

FCF / Share $-0.83 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

13-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$4.05M

↑ +115.6% —

Net Income Profit after all expenses

$-50.22M

↑ +17.2% —

FCF / Share Free cash flow per share

$-0.83

↑ +48.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

100

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Jan 31, 2020 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	115.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1345%)	25.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+214%)	56.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+611%)	-56.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-805%)	80.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+909%)	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	64.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-24.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-468.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	8.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	17.2% Good ↑ Good Improving Year-over-year change in net income	-118.4% Weak ↓ Weak Declining Year-over-year change in net income	61.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-13.7% Weak ↑ Weak Improving Year-over-year change in net income	-114.1% Weak ↓ Weak Declining Year-over-year change in net income	-33.5% Weak → Weak Stable Year-over-year change in net income	-42.4% Weak ↓ Weak Declining Year-over-year change in net income	18.7% Good ↑ Good Improving Year-over-year change in net income	-73.5% Weak ↓ Weak Declining Year-over-year change in net income	-27.9% Weak Weak Year-over-year change in net income	-75.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	48.7% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	47.4% Excellent Excellent Year-over-year change in free cash flow	99.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	61.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-5.1% Weak Weak Compound annual revenue growth over 3 years	7.3% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	27.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Jan 31, 2020 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Effective Tax Rate (%) (%)	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	17.5% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
FCF / Net Income (x)	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Jan 31, 2020 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	128.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	497.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-122.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-67.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-85.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-57.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-350.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-338.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-89.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	365.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-198.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-174.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-53.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-55.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-159.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-184.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-77.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-68.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	159.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+964%)	—	-135.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1005%)	-212.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1517%)	-98.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-755%)	-89.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-696%)	-72.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-585%)	—	—	-113.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-855%)	-83.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-659%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Jan 31, 2020 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Interest Coverage (x)	-561.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1453.36x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3590.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-749.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-471.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-142.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-130.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-107.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-144.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-384.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	-484.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-11.58M	$-8.64M	$-9.43M	$-19.99M	$-32.95M	$-7.14M	$-22.07M	$-8.03M	$-7.60M	$-10.17M	$-8.00M	$-257.00K	$-101.00K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Jan 31, 2020 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$0.13	$0.14	$0.20	$8.65	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.65	$-4.66	$-3.75	$-0.66	$-0.72	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.83	$-1.62	$-3.09	$-450.43	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-1.10	$-0.70	$2.48	$0.29	$0.71	$0.48	$0.54	$0.08	$0.14	$0.34	$0.41	—	—
Tangible Book Value per Share (USD)	$-1.10	$-1.54	$-4.37	$-0.23	$-0.16	$0.13	$0.38	$0.08	$0.14	$0.34	$0.41	—	—
Basic Weighted Avg Shares (shares)	30.48M	13.07M	7.65M	110,800	88,920	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Jan 31, 2020 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$3.23M	$4.48M	$3.50M	$13.43M	$25.02M	$230.00K	$18.52M	$3.08M	$4.07M	$8.42M	$8.61M	—	—
Total Equity (USD)	$-31.46M	$-12.27M	$20.47M	$34.29M	$65.22M	$33.48M	$30.84M	$3.42M	$4.40M	$9.86M	$10.42M	$-1.07M	$3.62M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Jan 31, 2020 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$4.05M	$1.88M	$1.50M	$958.00K	$2.20M	$1.22M	—	—	—	—	—	—	—
Depreciation Expense (USD)	$2.20M	$1.56M	$1.68M	$1.53M	$844.00K	$313.00K	$344.00K	$438.00K	$338.00K	$145.00K	$41.00K	$39.00K	—
Net Income, GAAP (USD)	$-50.22M	$-60.66M	$-27.78M	$-72.90M	$-64.10M	$-29.93M	$-22.43M	$-15.75M	$-19.38M	$-11.17M	$-8.73M	$-4.99M	—
Operating Cash Flow (USD)	$-22.18M	$-20.71M	$-23.32M	$-45.57M	$-35.94M	$-25.98M	$-19.71M	$-11.65M	$-13.38M	$-7.52M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 13 years · 48 quarters

Insight Molecular Diagnostics Inc.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IMDX with peers